Asset Details
Do you wish to reserve the book?
五次应用分子靶向药物治疗晚期肺癌患者1例
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
五次应用分子靶向药物治疗晚期肺癌患者1例
Do you wish to request the book?
五次应用分子靶向药物治疗晚期肺癌患者1例
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
五次应用分子靶向药物治疗晚期肺癌患者1例
2013
Overview
目前,表皮生长因子受体酪氨酸激酶抑制（epidermal growth factor receptor tyrosine kinase inhibitor,EGFR-TKI）在晚期非小细胞肺癌（non-small cell lung cancer,NSCLC）的治疗中取得了较好的疗效。但是,EGFR-TKI如何应用取得最佳治疗效果仍是亟待解决的问题。临床上针对EGFR-TKI明显获益的患者反复应用EGFR-TKI药物，可能取得较好的疗效。
We currently cannot retrieve any items related to this title. Kindly check back at a later time.